Colossal Biosciences announced Tuesday that it has simultaneously edited seven genes in mice embryos to create mice with long ...

On March 4th Colossal Biosciences, a company trying to revive long-gone species, announced that they had genetically ...

The animals, the first to have been created by Colossal Biosciences, have fluffy coats and curly whiskers.

Colossal Biosciences has altered several genes in mice to make them look more mammoth-like, but the company is far from its ...

Ben Lamm, CEO of the Dallas-based company with an estimated value over $10 billion, said the successful gene-editing of lab ...

The authors have demonstrated the use of adenine base editors delivered via adeno-associated viruses to introduce edits in the mitochondrial genome. The manuscript describes the methodology well, and ...

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech. | CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary ...